Lahjavida Bio Accepted to Present Tumor-Targeted Small-Molecule Drug Delivery Platform at AACR Annual Meeting 2026
COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company pioneering a new class of tumor-targeted small-molecule cancer therapies, today announced that an abstract describing its …